News und Pressemitteilungen
Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development
Pairing data-driven clinical-molecular insights with biological validation to identify relevant drug targets and confirm leads for biopharmaceutical companies Milan, Italy and Heidelberg, Germany – June 4, 2025 – Axxam S.p.A., a premier provider of integrated early discovery services, and Molecular Health GmbH, a leader in artificial intelligence (AI)-driven development solutions, are announcing a strategic collaboration […]
Integrated DNA Technologies and Molecular Health Ink Commercial Partnership
CORALVILLE, Iowa and HEIDELBERG, Germany (May 15, 2024)—Genomics solutions provider Integrated DNA Technologies (IDT) and Bio-IT company Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their next generation sequencing (NGS) capabilities. The partnership pairs IDT’s Archer NGS research assay platform with Molecular Health’s variant annotation and reporting software […]
St. Marianna University School of Medicine in Japan relies on MH Guide for personalized cancer medicine
Heidelberg, Germany/Kawasaki, Japan, October 27, 2023 – St. Marianna University School of Medicine in Kawasaki, Japan, will utilize MH Guide to personalize cancer treatment. The agreement between University School of Medicine and Molecular Health resulted from a preceding study partnership.The MH Guide system has been previously implemented at St. Marianna University Hospital, and a proof-of-concept […]
Molecular Health and Takara Bio collaborate to support Genome Medicine in Japan
Collaboration to introduce whole-genome sequencing with comprehensive variant annotation for Japanese patients affected by hereditary diseases.
Molecular Health erhält IVDR-Zertifikat für MH Guide
Molecular Health hat von der Europäischen Union die Zertifizierung für seine klinische Entscheidungsunterstützungssoftware MH Guide gemäß der neuen In-vitro-Diagnostik-Verordnung (EU) 2017/746 (IVDR) erhalten.
Molekulares Management des Mammakarzinoms: testen, analysieren, besprechen
Ein Symposium mit Prof. Dr. med. Christian Jackisch, Chefarzt am Sana Klinikum Offenbach, beim Factum-Kongress 2021
Events
| Bevorstehende Events | Wann | Wo |
|---|---|---|
| 37th European Congress of Pathology (ECP) | 6.-10. Sep | Wien, AT |
| OncoNet Rhein-Main: 19. Rhein-Main Symposium | 20. Sep | Frankfurt am Main (hybrid) |
| BioTechX Europe | 6.-8. Okt | Basel, CH |
| 12. Update prädiktive molekularpathologische Diagnostik | 17. Okt | Frankfurt am Main |
| Bio-Europe | 3.-5. Nov | Wien, AT |
| 15. Herbsttreffen der AG Molekularpathologie der DGP | 1.-2. Dez | Bonn |
| Vergangene Events | Wann | Wo |
|---|---|---|
| MH Guide Produktwebinar (in Englisch) “Intuitive by design, powerful in practice: MH Guide for precision oncology reporting“ | 17. Juni | online |
| 108. Jahrestagung der Deutschen Gesellschaft für Pathologie | 12.-14. Juni | Leipzig |
| OncoNet Rhein-Main: Neues aus Chicago | 11. Juni | Frankfurt am Main (hybrid) |
| Deutsche Biotechnologietage | 9.-10. April | Heidelberg |
| 16. TMF-Jahreskongress | 2.-3. April | Freiburg |
| Bio-Europe Spring | 17.-19. März | Mailand, IT |
| OncoNet Rhein-Main: Post San Antonio | 15. Jan | Frankfurt am Main (hybrid) |
| Lunch Learn Webinar „Integrierte, zielgerichtete Therapieempfehlungen im molekularpathologischen Befund„ | 17. Sep 2024 | online |
| Live-Seminar (only in German) „Rare tumors, challenges in clinical and diagnostic practice„ (CME webinar) | 13. März 2024 | Online |